These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 33249398)
1. Ectopic expression of KLK6 in MDA-MB-435 melanoma cells reduces tumorigenicity in vivo. Pampalakis G; Zingkou E; Zoumpourlis V; Sotiropoulou G Pathol Res Pract; 2021 Jan; 217():153276. PubMed ID: 33249398 [TBL] [Abstract][Full Text] [Related]
2. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition. Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923 [TBL] [Abstract][Full Text] [Related]
3. Biochemical pathways mediated by KLK6 protease in breast cancer. Pampalakis G; Zingkou E; Sidiropoulos KG; Diamandis EP; Zoumpourlis V; Yousef GM; Sotiropoulou G Mol Oncol; 2019 Nov; 13(11):2329-2343. PubMed ID: 30980596 [TBL] [Abstract][Full Text] [Related]
4. KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes. Sidiropoulos KG; Ding Q; Pampalakis G; White NM; Boulos P; Sotiropoulou G; Yousef GM Mol Oncol; 2016 Aug; 10(7):993-1007. PubMed ID: 27093921 [TBL] [Abstract][Full Text] [Related]
6. Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment. Krenzer S; Peterziel H; Mauch C; Blaber SI; Blaber M; Angel P; Hess J J Invest Dermatol; 2011 Nov; 131(11):2281-8. PubMed ID: 21753781 [TBL] [Abstract][Full Text] [Related]
7. Expression of Kallikrein-Related Peptidase 6 in Primary Mucosal Malignant Melanoma of the Head and Neck. Thierauf J; Veit JA; Lennerz JK; Weissinger SE; Affolter A; Döscher J; Bergmann C; Knopf A; Grünow J; Grünmüller L; Mauch C; Plinkert PK; Hoffmann TK; Hess J Head Neck Pathol; 2017 Sep; 11(3):314-320. PubMed ID: 27844409 [TBL] [Abstract][Full Text] [Related]
8. Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer. Kim TW; Lee SJ; Kim JT; Kim SJ; Min JK; Bae KH; Jung H; Kim BY; Lim JS; Yang Y; Yoon DY; Choe YK; Lee HG Oncotarget; 2016 Dec; 7(51):85332-85348. PubMed ID: 27863404 [TBL] [Abstract][Full Text] [Related]
9. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6. Sells E; Pandey R; Chen H; Skovan BA; Cui H; Ignatenko NA Neoplasia; 2017 May; 19(5):396-411. PubMed ID: 28431272 [TBL] [Abstract][Full Text] [Related]
11. High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis. Nathalie HV; Chris P; Serge G; Catherine C; Benjamin B; Claire B; Christelle P; Briollais L; Pascale R; Marie-Lise J; Yves C J Cell Mol Med; 2009 Sep; 13(9B):4014-22. PubMed ID: 19426157 [TBL] [Abstract][Full Text] [Related]
12. Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. Pampalakis G; Sotiropoulou G Biol Chem; 2006 Jun; 387(6):773-82. PubMed ID: 16800739 [TBL] [Abstract][Full Text] [Related]
13. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients. Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Nagahara H; Mimori K; Utsunomiya T; Barnard GF; Ohira M; Hirakawa K; Mori M Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6800-6. PubMed ID: 16203767 [TBL] [Abstract][Full Text] [Related]
15. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors. Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481 [TBL] [Abstract][Full Text] [Related]
16. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer. Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672 [TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion. Delaunay T; Deschamps L; Haddada M; Walker F; Soosaipillai A; Soualmia F; El Amri C; Diamandis EP; Brattsand M; Magdolen V; Darmoul D Mol Oncol; 2017 Oct; 11(10):1330-1347. PubMed ID: 28636767 [TBL] [Abstract][Full Text] [Related]
19. Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors. Talieri M; Zoma M; Devetzi M; Scorilas A; Ardavanis A Tumour Biol; 2012 Oct; 33(5):1375-83. PubMed ID: 22477710 [TBL] [Abstract][Full Text] [Related]
20. Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer. Kim JJ; Kim JT; Yoon HR; Kang MA; Kim JH; Lee YH; Kim JW; Lee SJ; Song EY; Myung PK; Lee HG Tumour Biol; 2012 Jun; 33(3):731-8. PubMed ID: 22373580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]